![How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data. - ppt download How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data. - ppt download](https://images.slideplayer.com/23/6590870/slides/slide_3.jpg)
How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data. - ppt download
![Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol](https://bmjopen.bmj.com/content/bmjopen/3/7/e002902/F1.large.jpg)
Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol
![Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial - The Lancet Neurology Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/e53ef392-4fec-49e2-b653-2896383e183d/gr1.gif)
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial - The Lancet Neurology
![PDF] Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition. | Semantic Scholar PDF] Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/814ad6ccbfa9defca4d2b00c4672f9070cf6b8da/16-Figure1-1.png)
PDF] Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition. | Semantic Scholar
PLOS ONE: A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults
![Study design schematic for the open-label extension study. AE, adverse... | Download Scientific Diagram Study design schematic for the open-label extension study. AE, adverse... | Download Scientific Diagram](https://www.researchgate.net/profile/Herbert-Baraf/publication/233396586/figure/fig4/AS:289187577253918@1445959099647/Figure1-Study-design-schematic-for-the-open-label-extension-study-AE-adverse-event-IR.png)
Study design schematic for the open-label extension study. AE, adverse... | Download Scientific Diagram
![An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-019-1857-3/MediaObjects/13075_2019_1857_Fig1_HTML.png)
An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text
PLOS Neglected Tropical Diseases: Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial
![A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13063-019-3766-9/MediaObjects/13063_2019_3766_Fig1_HTML.png)
A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults
![Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study). | Semantic Scholar Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1cddd261551d50318e376dfb82aed83eb00d7466/4-Table1-1.png)
Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study). | Semantic Scholar
![PDF] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial | Semantic Scholar PDF] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/60afa7902fddea770036d6744ee84027545bd238/3-Figure1-1.png)
PDF] Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial | Semantic Scholar
![Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo - eClinicalMedicine Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/618f5366-326d-4aac-9d85-05c9687bd2d1/gr1_lrg.jpg)
Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo - eClinicalMedicine
![An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study) - Kidney International An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study) - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/140b9fc4-faa7-46ec-9698-8d6ec89b3952/fx1.jpg)
An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study) - Kidney International
![Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals Understanding Clinical Trial Terminology: What is an Open Label Clinical Trial? - Concert Pharmaceuticals](https://www.concertpharma.com/wp-content/uploads/2019/06/clinicaltrials-2-e1566478031946.jpg)